Self‑questionnaire to spot rare genetic bone conditions in adults with osteoporosis
Official title: Clinical Validation of a Self-questionnaire in Adults With Osteoporosis
Run by CHU de Quebec-Universite Laval · NCT07067827 · Data updated 2026-11-12
This project tests whether a self‑administered questionnaire can help identify rare genetic bone diseases in adults with osteoporosis.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 58 (estimated) |
| Sponsor | CHU de Quebec-Universite Laval Academic / other |
| Drugs / interventions | prednisone |
| Locations | 1 site (Québec, Quebec) |
| Status | Recruiting |
| Started | April 1, 2026 |
| Main results expected | July 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | May 8, 2026 |
| Trial ID | NCT07067827 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age ≥18) with osteoporosis who are followed in the rheumatology or endocrinology clinics at CHU de Québec–Université Laval and who have internet access are the intended participants.
✕Probably not a fit
People who cannot consent or complete questionnaires, those with unknown family history (for example, adopted persons), or those without internet access are unlikely to benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will compare answers from a self‑administered questionnaire to information collected by telephone using a family tree to test the questionnaire's validity. Participants are adults with osteoporosis followed at CHU de Québec–Université Laval and will be randomized to complete either the questionnaire or the family‑tree interview first, with the other method repeated three months later. Clinical and sociodemographic data will be extracted from electronic medical records to describe participants and disease severity. The goal is to see how well the questionnaire matches the family‑tree information and to adapt it to improve accuracy for clinical screening.
Why it matters
Potential benefit: If successful, the questionnaire could make it easier to detect rare genetic bone diseases earlier and enable more personalized care for people with osteoporosis.
How similar studies have gone: Self‑reported family‑history questionnaires have been used in other genetic risk screenings with mixed accuracy, and this specific questionnaire is newly developed by the team and has not yet been validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult over 18 * Followed by the rheumatology or endocrinology clinics at the CHUL (CHU de Quebec-Universite Laval) * Suffer from osteoporosis * Have internet access Exclusion Criteria: * Unfit, unable to consent, unable to answer a questionnaire, unknown family history (e.g. adopted person)
Where it's running
-
CHU de Quebec-Universite Laval
Québec, Quebec, Canada Recruiting
Study contacts
- Principal investigator: Laetitia Michou, MD PhD — CHU de Quebec-Universite Laval
- Study coordinator: Laetitia Michou, MD PhD
- Email: laetitia.michou@crchudequebec.ulaval.ca
- Phone: +14185254444
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Role of LH and hCG in adults being evaluated for endocrine disorders
This study looks at whether levels of luteinizing hormone (LH) and hCG in adults undergoing endocrine evaluation relate to their disease presence and outcomes.
-
Can a blood marker called lumican reveal hidden fragility in postmenopausal osteoporosis
This study tests whether serum lumican levels can help identify hidden fragility risk in postmenopausal women beyond what bone density shows.
-
Functional Muscle-Bone Incongruity Index: A look at muscle strength and bone health in adults
This observational study tests a composite FKUI score using handgrip strength and hip/spine bone density to see if it better reflects musculoskeletal health than each measure alone in adults undergoing routine DXA.
-
Vessel-X Bone Filling Container System for Vertebral Augmentation
A new minimally invasive vertebral augmentation approach tests the Vessel-X device to see if it safely improves pain and function in people with osteoporotic vertebral compression fractures.
-
Proximal Humerus Cortical Thickness in Post-Stroke Paresis
This study tests whether measurements of the outer bone thickness of the upper arm (the humerus) on the paretic side after a stroke reflect regional bone loss and how well they agree with standard bone density tests.
-
People with Osteoporosis: See if Walk-BEST Gait Program Helps You Walk Safer
This pilot study tests whether older adults with osteoporosis can use the Walk-BEST gait training with a wearable sensor to walk more safely and reduce fall risk.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.